Related Experiment Video
Updated: Oct 10, 2025

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
COGNITIVE FUNCTIONS IN MULTIPLE SCLEROSIS PATIENTS DEPENDING ON THE DIFFERENT RISK FACTORS PRESENCE
Oksana O Kopchak1, Tetiana A Odintsova1, Oleksandr R Pulyk2
1DEPARTMENT OF NEUROLOGY, PSYCHIATRY AND PHYSICAL REHABILITATION, KYIV MEDICAL UNIVERSITY, KYIV, UKRAINE.
Objective:
The aim: To clarify the influence of different risk factors on cognitive impairment (CI) in general and in separate domains and their association with MRI findings in patients with relapsing-remitting (RRMS) and progressive forms of multiple sclerosis (SPMS and PPMS).
Patients And Methods:
Materials and methods: One hundred and thirty-seven participants with MS (102 females and 35 males) aged from 22 to 69 years were enrolled into this study. All patients completed the Montreal Cognitive Assessment (MoCA), Beck Depression Inventory (BDI), Hamilton Anxiety Rating Scale (HAM-A) and undergone MRI.
Results:
Results: According to MS phenotypes all participants were divided into two groups: patients with RRMS (n= 106) and with progressive phenotypes (n= 31). A significant positive correlation was present between MoCA and BDI scores in all participants (p= 0,0015). Presence of anxiety did not demonstrate any valid influence on cognitive performance, although severe anxiety was significantly more often found in subjects with progressive phenotypes in presence of brain atrophy (p= 0,0028). Patients with higher education had no CI more frequently compare to those without it (p= 0,0019), whereas, participants smoking cigarettes had higher prevalence of severe CI than non-smokers (p= 0,0061).
Conclusion:
Conclusions: Among cognitive domains memory, visual-spatial and executive functions, abstract thinking were impaired the most in MS patients, though abstract thinking was more often affected in progressive forms. The results demonstrated that physical disability, depression and smoking negatively impacted cognitive performance, meanwhile presence of higher education demonstrated a favorable influence on cognition in MS patients.
Insights
Cognitive impairment in multiple sclerosis is influenced by depression, smoking, and education level. Progressive MS forms show more abstract thinking deficits, with anxiety linked to brain atrophy.
Area of Science:
- Neuroscience
- Clinical Neurology
- Cognitive Science
Background:
- Multiple Sclerosis (MS) is a chronic neurological disease affecting cognitive function.
- Cognitive impairment (CI) is a common and debilitating symptom in MS.
- Understanding risk factors for CI is crucial for managing MS patients.
Purpose of the Study:
- To investigate the impact of various risk factors on cognitive impairment in relapsing-remitting MS (RRMS) and progressive MS (PMS).
- To explore the association between cognitive domains, risk factors, and MRI findings in MS.
- To differentiate cognitive profiles between RRMS and PMS phenotypes.
Main Methods:
- 137 MS patients (102 female, 35 male) aged 22-69 years were assessed.
- Cognitive function was evaluated using the Montreal Cognitive Assessment (MoCA).
- Psychological status was assessed via Beck Depression Inventory (BDI) and Hamilton Anxiety Rating Scale (HAM-A); MRI scans were performed.
Main Results:
- Higher education correlated with less cognitive impairment (p=0.0019).
- Smoking was associated with a higher prevalence of severe CI (p=0.0061).
- Depression showed a significant positive correlation with MoCA scores (p=0.0015), and severe anxiety was linked to brain atrophy in progressive MS (p=0.0028).
Conclusions:
- Memory, visual-spatial, executive functions, and abstract thinking are most affected in MS.
- Abstract thinking deficits were more pronounced in progressive MS phenotypes.
- Physical disability, depression, and smoking negatively impact cognition; higher education has a protective effect.
Related Concept Videos
Role of Cerebellum and Prefrontal Cortex in Memory
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Language and Cognition
Cognitive Development During Adulthood

